![George J. Vergis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George J. Vergis
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von George J. Vergis
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Neose Technologies, Inc.
![]() Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.
22
| Extinct | Pharmaceuticals: Major | 22 |
Knoll Pharmaceutical Co.
9
| Subsidiary | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von George J. Vergis
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
Purdue University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer | |
ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
BASF Pharma Ltd.
![]() BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
Fairleigh Dickinson University | College/University | Graduate Degree Director/Board Member | |
NOVADEL PHARMA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedImmune Vaccines, Inc.
![]() MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | President Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
U.S. Bioscience, Inc.
![]() U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Biotechnology | Director of Finance/CFO President | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Biotechnology Institute
![]() The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
The Wistar Institute
![]() The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Corporate Officer/Principal | |
National Venture Capital Association
![]() National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Allos Therapeutics, Inc.
![]() Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Nevada
![]() University of Nevada Other Consumer ServicesConsumer Services University of Nevada functions as a college and university. It provides education, research, scholarship, creative activities, and clinical services. The company was founded on September 10, 1957 and is headquartered in Las Vegas, NV. | College/University | Undergraduate Degree | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Sales & Marketing | |
CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Hip Innovation Technology LLC | Founder | ||
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director of Finance/CFO | |
Scilex, Inc.
![]() Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
Isarna Therapeutics, Inc. | Director of Finance/CFO | ||
DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
SCILEX Pharmaceuticals, Inc.
![]() SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
Licensing Executives Society | Corporate Officer/Principal | ||
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ALTIMMUNE, INC. | Biotechnology | Director of Finance/CFO | |
JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal | |
Marshall University | College/University | Undergraduate Degree | |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
AFFYMAX, INC. | Biotechnology | Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 49 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Sektoral
Health Technology | 30 |
Consumer Services | 10 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Operativ
Director/Board Member | 165 |
Corporate Officer/Principal | 86 |
Independent Dir/Board Member | 41 |
Chairman | 33 |
Undergraduate Degree | 27 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Brian H. Dovey | 40 |
Paul Neff | 33 |
Elizabeth Czerepak | 32 |
Mark Rachesky | 30 |
Leonard Patrick Gage | 26 |
H. Parker | 22 |
Robert Stewart | 20 |
Kathryn Gregory | 16 |
Kenneth Kashkin | 15 |
C. Boyd Clarke | 15 |
William F. Hamilton | 13 |
Douglas Kling | 12 |
Melvin Spigelman | 11 |
Elizabeth Hamilton Seabury Wyatt | 11 |
Gary D. Dolch | 10 |
- Börse
- Insiders
- George J. Vergis
- Unternehmensverbindungen